Professional Summary »
Specializing In »
Practice Locations »
Patient Ratings »
Referring Physicians »
Biography
Dr. Gupta specializes in the treatment of patients with lymphoma in general, and has particular clinical and research interests in patients with primary central nervous system and immunodeficiency-related lymphomas.
View Full Biography »
Professional Summary
Education & Certifications
- Fellowship: UCSF Hematology and Medical Oncology Fellowship (2013) CA
- Board Certification: American Board of Internal Medicine, Medical Oncology (2013)
- Residency: University of Washington Medical Center Dept of Medicine (2010) WA
- Medical Education: University of California Davis School of Medicine (2006) CA
- Fellowship: Memorial Sloan-Kettering Cancer Center (2009) NY
- Board Certification: American Board of Internal Medicine, Hematology (2014)
Honors & Awards
- Saul Rosenberg Faculty Teaching Award, Division of Oncology, Department of Medicine (2018)
- Saul Rosenberg Faculty Teaching Award, Division of Oncology, Department of Medicine (2020)
Publications
-
New Meets Old: A Case Study and Review of Novel Therapeutics for the Treatment of CLL in Older Patients
Gupta, N. K., & Andreadis, C. (2014). New Meets Old: A Case Study and Review of Novel Therapeutics for the Treatment of CLL in Older Patients. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(10), 1371–75. -
How I treat CNS lymphomas
Rubenstein, J. L., Gupta, N. K., Mannis, G. N., LaMarre, A. K., & Treseler, P. (2013). How I treat CNS lymphomas. BLOOD, 122(14), 2318–30. -
Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma
Gupta, N. K., Barker, J. N., Young, J. W., & Noy, A. (2009). Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma. LEUKEMIA & LYMPHOMA, 50(12), 2075–2077. -
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis
Mannis, G. N., Logan, A. C., Leavitt, A. D., Yanada, M., Hwang, J., Olin, R. L., … Martin, T. G. (2015). Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. BONE MARROW TRANSPLANTATION, 50(1), 40–44. -
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium
Bayraktar, U. D., Ramos, J. C., Petrich, A., Gupta, N., Lensing, S., Moore, P. C., … Noy, A. (2012). Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium. LEUKEMIA & LYMPHOMA, 53(12), 2383–2389. -
Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing
Martin, W. J., Gupta, N. K., Loo, C. M., Rohde, D. S., & Basbaum, A. I. (1999). Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. PAIN, 80(1-2), 57–65. -
The Transfusion Tether: Bridging the Gap Between End-Stage Hematologic Malignancies and Optimal End-of-Life Care.
Mannis, G. N., McNey, L. M., Gupta, N. K., & Gross, D. M. (2016). The Transfusion Tether: Bridging the Gap Between End-Stage Hematologic Malignancies and Optimal End-of-Life Care. American Journal of Hematology. -
Diffuse Large B-cell Lymphoma
Gupta, N. K., & Kaplan, L. D. (2014). Diffuse Large B-cell Lymphoma. Cancers in People with HIV and AIDS (pp. 175–182). Springer. -
Long-term survival in AIDS-related primary central nervous system lymphoma.
Gupta, N. K., Nolan, A., Omuro, A., Reid, E. G., Wang, C.-C. C., Mannis, G., … Rubenstein, J. L. (2016). Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro-Oncology. -
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2016). Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. SCIENCE TRANSLATIONAL MEDICINE, 8(364). -
Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma
Scherer, F., Kurtz, D. M., Newman, A. M., Esfahani, M. S., Craig, A., Stehr, H., … Alizadeh, A. A. (2016). Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma. BLOOD. SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC HEMATOLOGY. -
Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis
Chu, M. P., Brody, J., Kohrt, H. E., Frank, M. J., Khodadoust, M., Reddy, S., … Levy, R. (2015). Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis. BLOOD. AMER SOC HEMATOLOGY. -
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.
Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2018785246. -
Cancer in People Living With HIV, Version 1.2018 Clinical Practice Guidelines in Oncology
Reid, E., Suneja, G., Ambinder, R. F., Ard, K., Baiocchi, R., Barta, S. K., … Freedman-Cass, D. A. (2018). Cancer in People Living With HIV, Version 1.2018 Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 16(8), 986–1017. -
Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations
Jan, M., Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Liu, C. L., … Alizadeh, A. A. (2016). Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations. BLOOD. AMER SOC HEMATOLOGY. -
Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
Kurtz, D. M., Scherer, F., Newman, A. M., Craig, A., Jin, M., Stehr, H., … Alizadeh, A. A. (2016). Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY. -
Circulating tumor DNA (ctDNA) in B-cell lymphoma
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating tumor DNA (ctDNA) in B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. WILEY. -
Reply to J. Wang et al.
Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F., Esfahani, M. S., … Alizadeh, A. A. (2019). Reply to J. Wang et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO1801907. -
AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Reid, E., Suneja, G., Ambinder, R. F., Ard, K., Baiocchi, R., Barta, S. K., … Freedman-Cass, D. A. (2019). AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 17(2), 171–89. -
Prognostic Value of Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma Reply
Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2019). Prognostic Value of Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma Reply. JOURNAL OF CLINICAL ONCOLOGY, 37(9), 755-+. -
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 36(28), 2845-+. -
AIDS-Related Kaposi Sarcoma, Version 2.2019
Reid, E., Suneja, G., Ambinder, R. F., Ard, K., Baiocchi, R., Barta, S. K., … Freedman-Cass, D. A. (2019). AIDS-Related Kaposi Sarcoma, Version 2.2019. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 17(2), 171–89. -
Noninvasive molecular subtyping and risk stratification of DLBCL.
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2016). Noninvasive molecular subtyping and risk stratification of DLBCL. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphoma.
Gupta, S., Long, S. R., Natkunam, Y., Kong, C. S., Gupta, N. K., & Gratzinger, D. (2020). Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphoma. Cancer Cytopathology. -
Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium
Noy, A., Lensing, S. Y., Moore, P. C., Gupta, N., Aboulafia, D., Ambinder, R., … Chadburn, A. (2016). Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. LEUKEMIA & LYMPHOMA, 57(7), 1731–34. -
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
Frank, M. J., Khodadoust, M. S., Czerwinski, D. K., Haabeth, O. A., Chu, M. P., Miklos, D. B., … Levy, R. (2020). Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial. The Journal of Experimental Medicine, 217(9). -
Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy.
Binkley, M. S., Hiniker, S. M., Younes, S., Yoo, C., Wignarajah, A., Jin, M., … Hoppe, R. T. (2021). Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy. Leukemia & Lymphoma, 1–15. -
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Pre-Established Immunity.
Shree, T., Shankar, V., Lohmeyer, J. J., Czerwinski, D. K., Schroers-Martin, J. G., Rodriguez, G. M., … Levy, R. (2022). CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Pre-Established Immunity. Blood Cancer Discovery. -
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Sehgal, A., Hoda, D., Riedell, P. A., Ghosh, N., Hamadani, M., Hildebrandt, G. C., … Gordon, L. I. (2022). Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study. The Lancet. Oncology. -
Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma
Shree, T., Shankar, V., Czerwinski, D. K., Rodriguez, G., Beygi, S., Schroers-Martin, J. G., … Levy, R. (2021). Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY. -
Lisocabtagene maraleucel (liso-cel) as second-line (2L) therapy for R/R large B-cell lymphoma (LBCL) in patients (pt) not intended for hematopoietic stem cell transplantation (HSCT): Primary analysis from the phase 2 PILOT study.
Sehgal, A., Hoda, D., Riedell, P. A., Ghosh, N., Hamadani, M., Hildebrandt, G., … Gordon, L. I. (2022). Lisocabtagene maraleucel (liso-cel) as second-line (2L) therapy for R/R large B-cell lymphoma (LBCL) in patients (pt) not intended for hematopoietic stem cell transplantation (HSCT): Primary analysis from the phase 2 PILOT study. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma.
Bojanini, L., Gupta, N., & Khaki, A. R. (2023). Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma. The Oncologist. -
Lisocabtagene Maraleucel as Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplant: Final Analysis of the Phase 2 PILOT Study
Sehgal, A. R., Hoda, D., Riedell, P. A., Ghosh, N., Hamadani, M., Hildebrandt, G., … Gordon, L. I. (2023). Lisocabtagene Maraleucel as Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplant: Final Analysis of the Phase 2 PILOT Study. BLOOD. AMER SOC HEMATOLOGY.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006) »
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia »
- Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087) »
- A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO) »
- Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma »
- Investigation of Tipifarnib in Treatment of Subjects With PTCL That Have Not Responded to Standard Therapy. »
- Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies »
- Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma »
Practice Locations
Lymphoma Program Palo Alto, CA
Palo Alto, CA
Lymphoma Program
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Lymphoma Program in Palo Alto Palo Alto, CA
Palo Alto, CA
Lymphoma Program in Palo Alto
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(141 reviews)
He’s a wonderful doctor and a very compassionate person
Dr. Gupta and his team are excellent!
Dr. Gupta has kept me alive for the past three years and I am eternally grateful to him and Stanford for that. I feel that Dr. Gupta has become more like a friend than a doctor to me. I am certain that I can become a difficult patient at times but Dr. Gupta has been patient and caring throughout this process. I feel extremely lucky to have Dr. Gupta be my guide in this final phase of my life.
Best doctor I could possibly ask for. Always takes time to answer all my questions and makes me feel reassured about my health concerns.
He is a great Dr. and human being.
Dr Gupta is excellent and kind
Superb
Thank you for being thorough and intentional and willing to take my thoughts into consideration!
A very caring and thoughtful Doctor. I’m glad I am his patient
Couldn't ask for a more outstanding doctor!!
Excellent Dr and very thorough and explains things well.
Very good to visit with and great full for all his advise as to the direction of further treatment
He’s very kind and listens to my concerns.
Dr. Gupta Neel is a great doctor who is very professional and kindly.
Friendly and efficient
Dr. Gupta and his team are the BEST
I was delighted that PA Samantha Kramer offered a video conference with her and Dr. Gupta. Samantha had seen that I had a procedure 2 days prior to my appointment and knew that a video conference would be as effective as an in person visit. It was a relief for my husband and I to avoid a snarky commute to Stanford again.
The visit with Samantha and the following visit with Dr. Gupta and Betty, RN coordinator couldn’t have been better. All information was shared easily and all of my questions were answered. All of the provider’s empathy to my situation was not lost in the video visit. I will always opt in for video visits in the future if my provider feels it is an option.
Dr Gupta is an excellent doctor and so compassionate and personable
Could not have a better doctor!
Stanford is the best in the country.
Well trained staff!!
Very impressed with the hospital, my first visit.
Always a great visit with Dr. Gupta
Dr Neel Gupta is an excellent physician. He’s caring, knowledgeable and takes the time to explain every aspect of treatments available for my particular situation. I couldn’t ask for a better doctor.
Dr.Gupta is an excellent oncologist and a really great person. He knows how to connect with me and his advice and suggestions have always been right on. I am very glad he is my physician.
Dr. Gupta has been wonderful to work with. I appreciate his flexibility and relatability. Very informative and personable at the same time.
I love my Doctor. I came in early for my visit, & wow, he must of had light day, I saw him an hour early. He's caring, attentive & informative!
Everyone was friendly, kind & professional. Outstanding in every way
He is a wonderful and caring Doctor
Dr. Gupta is knowledgeable, well prepared, answers all of my questions and just is a very pleasant person
five stars. grateful!
The best!
Great Doctor and very interesting guy
I love my doctor
Dr. Gupta and his team are incredible! I can't say enough about their care, expertise, and kindness!
Dr. Gupta is a warm, caring doctor. He has a positive, reassuring approach.
Everything was perfect
Great, as always
Dr. Gupta is wonderful
You are my best friend. great day. I love you all of you.
Outstanding, exceptional physician. Outstanding person.
Dr. Gupta is an extremely competent and caring physician.
Dr. Gupta and his team done an excellent job love it we need more doctor like this 👠👠👠👠👠🙠🙠🙠🙠🙠🥇🥇🥇🥇🥇
He and his team are the best!
Incredible doctor and staff. Very caring , concern with my wellbeing .
Dr Gupta and Samantha K. PA are awesome!
Excellent listener and communicator. Very willing to answer my questions honestly.
Dr. Neel Gupta and team are treasures and Stanford is lucky to have them.
Many thanks to Dr. Gupta and Dr. Sam for today's visit.
I think he’s a wonderful doctor!!
Dr Gupta is pretty awesome! He is thorough and thoughtful. He also comes across as very caring. I mentioned that I had a trip in early February, and because of his genuine concern(Covid spike throughout the world)I canceled my trip and plan on taking it in 6 months (hopefully covid numbers will be better).
He is the BEST !
Dr. Gupta is the very BEST
Dr. Gupta has always been cordial and professional with me and my care and I am grateful to have him and his staff working with me regarding my care.
Dr. Gupta is The Best!!
Very professional.
Dr. Gupta is kind, thoughtful and compassionate... as well as personable. He always makes me feel comfortable and relaxed. I know he cares about my health.
Great and understanding
Doctor
Dr Gupta is wonderful. Very informative and interested in answering any questions I have. His assistant is also extremely helpful. I feel very fortunate to have Dr. Gupta and his medical team helping me with my medical needs.
Professional and knowledgeable Physician and team leader.
Caring and empathy with patient.
Clear communication and cordial.
Absolutely
Dr Gupta has been a tremendous part of our healing team and we are grateful for his time and expertise. He's kept our mom alive for many years now and he truly cares about her and about our family.
The highest recommendation!
Listens well. Explains well.
Dr. Gupta and associates are very good and professional.
Great Doctor. Lucky to have his expertise
Fabulous doctor!
Good doctor, nice guy. He's a keeper.
Dr Gupta and his staff have given me the best of care over the past three years.
service is exceptional. everyone there always has an extreme positive attitude.
I would highly recommend Stanford health care
Dr. Gupta was a Good listener, Kind, take a time to answer my questions
I am well pleased with Dr. Gupta and another woman doctor.
They were all very thorough in their explanations and my concerns.
Very good.
Dr. Gupta is the best!
Dr Gupta was great in giving me the results of my recent blood work & answered my questions.
He remembered the day before was my birthday!
Dr. Gupta is an excellent Dr. and human being.
I have been seeing Dr. Gupta for a few years now. He is an outstanding doctor! He always listens to my concerns and explains things in a way I understand.
Always.
Dr. Gupta did great job of explaining options available for cancer treatments. Was very happy how I was treated by medical staff.
Excellent.
Top notch explanation & discussion.
Excellent - Dr. Gupta.
Care giver & his assistant was great both very pleasant & showed real concern - took the time to explain.
I never feel rushed with Dr. Gupta. He is extremely good about explaining everything, making me feel comfortable. He is a very wonderful dr.
Dr. Gupta is and has been excellent in his care and advice at each appointment. He is extremely good at listening to any concerns and providing expert assistance when assisting with any concerns, questions, etc. he is professional and we are fortunate to have him as our doctor.
Dr. Gupta & the other oncologists super good!!!
Dr. Gupta saved my life!
Dr. Gupta and his staff are the best. They always take the time to answer any questions and address any concerns.
Dr. Gupta is very personable, compassionate, easy to understand.
Dr. Gupta & his team are the best! I'm very lucky to have such great professionals working on my healthcare!
Dr. Neel Gupta is knowledgeable, professional. Caring and courteous. We can always recommend him to others!
Dr. Gupta is the best.
Very satisfied w/explanation of my medical problem @ this time & showing me the new area of cancer on the PET scan. It helped me understand a little more clearly.
Dr. Gupta is the best physician I have met in 30 years of medical administration, he is pleasant and informative.
Very good experience.
Both physician & NA were very clear with their explanation of my condition & the plan of action they recommended & shared with my oncologist & also were very patient with our questions & concerns.
Doctors Neel Gupta and Dr. Hoppe are top notch!
My experiences with Dr. Gupta have been amazing! He knows what he is doing! I felt he had my healing at the center of all his thoughts! I felt (and feel) involved and part of the team effort! Dr. Gupta is one of the few people in this world I TOTALLY trust!
Love Dr. Neel!!
Doctor & PA always have good eye contact with myself and wife when visiting or explaining, meds, procedures, condition, progress, the future.
Making Dr. Gupta and Stanford hospital my primary cancer care was the best decision I could have made. Thank you!
Very personable staff, good eye contact with my wife and me, never thought we were rushed.
Dr. Gupta is amazing.
Dr. Gupta is awesome!
Dr. Gupta is a great doc!
I appreciated that Dr. Gupta did not interrupt my appointment when he received a text about another patient. Instead he asked someone else to handle the issue.
Very good!!
Excellent best of care.
We arrived late due to glitches with our insurance (medical group) not allowing the CT scan at Stanford but Dr. Gupta was gracious enough to wait for us and gave us his time.
Looking forward to the return visit.
Yes, I would recommend other people.
Outstanding experience. Doctor seemed knowledgeable and experienced in treating my specific type of lymphoma (which is a more care type).
All excellent.
Very knowledgeable, experienced, relay the plan in layman terms.
I have total respect & trust in Dr. Gupta. Couldn't ask for a better doc.
Excellent care with all providers.
Dr. Gupta & his team are AMAZING - I feel blessed to be under their care.
I have so many miles to travel - sometimes hard finding a driver, but that is my problem. Stanford is great!
If it wasn't 185 miles from home, I would like to make you my primary oncologist.
They saved my life!
Dr. Gupta is a wonderful dr. and person, and his nurse. I was lucky to have them.
I can't say enough wonderful things; with something as terrifying as cancer, Dr. Gupta makes it all seem manageable. His compassion & ability to communicate a clear plan are appreciated beyond words.
We love Dr. Gupta. Lindsay and Betty they are the BEST team to take care of me. I can't thank them enough to truly show my appreciation. I feel so lucky to have them as my care provider, thank you, Dr. Gupta!
I cannot express how good Dr. Gupta and Lindsay Stringer, PA are. I have spent 35 years in the field and they are exceptional.
Dr. Gupta was great - I'm glad they switched me. Too bad it's a 3 hour drive to see him!!
Lindsay and Betty are great, so is Dr. Gupta!
Very professional and friendly.
Dr. Gupta contacted my Kaiser doctor to discuss results of my visit to Stanford - Good experience.
Doctors and nurse very good to take care patients or me.
Wonderful doctor.
Excellent patient skills
I was especially pleased that he was patient and not rushed. In addition I was also impressed that Dr. Gupta himself called me at home to assure me of the results of testing.
The care was fine.
Dr. Gupta is an excellent doctor and I am very comfortable with him. I felt very confident having him as my physician.
Dr. Gupta is the best!
My whole family loves Dr. Gupta & his assistant, Ms. Lindsay Stringer. They are simply the BEST!
I didn't have many questions about the medications or follow-up care but it was discussed.
We love DR. GUPTA.
I am better because of the care & decisions we've made together.
Dr. & nurse practitioner have always been very supportive. I love them!
View More »
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records